HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA - NYSE:DOC - US42250P1030 - REIT
19.37 USD
+0.19 (+0.99%)
19.6067 USD
+0.24 (+1.22%)
DOC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. There are concerns on the financial health of DOC while its profitability can be described as average. DOC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
Each year in the past 5 years DOC has been profitable.
DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DOC has a Return On Assets (0.83%) which is in line with its industry peers.
With a Return On Equity value of 2.07%, DOC perfoms like the industry average, outperforming 52.71% of the companies in the same industry.
The Return On Invested Capital of DOC (2.07%) is worse than 60.47% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 2.07% | ||
| ROIC | 2.07% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
DOC has a Profit Margin of 5.87%. This is comparable to the rest of the industry: DOC outperforms 54.26% of its industry peers.
DOC's Profit Margin has improved in the last couple of years.
DOC has a Operating Margin (17.78%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DOC has declined.
DOC has a worse Gross Margin (60.51%) than 65.12% of its industry peers.
In the last couple of years the Gross Margin of DOC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.78% | ||
| PM (TTM) | 5.87% | ||
| GM | 60.51% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DOC has been increased compared to 1 year ago.
Compared to 5 years ago, DOC has more shares outstanding
Compared to 1 year ago, DOC has about the same debt to assets ratio.
2.2 Solvency
DOC has an Altman-Z score of 0.47. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
DOC's Altman-Z score of 0.47 is in line compared to the rest of the industry. DOC outperforms 48.84% of its industry peers.
DOC has a debt to FCF ratio of 17.80. This is a negative value and a sign of low solvency as DOC would need 17.80 years to pay back of all of its debts.
DOC has a Debt to FCF ratio of 17.80. This is in the better half of the industry: DOC outperforms 79.07% of its industry peers.
DOC has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
DOC has a Debt to Equity ratio (1.14) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 17.8 | ||
| Altman-Z | 0.47 |
ROIC/WACC0.32
WACC6.48%
2.3 Liquidity
DOC has a Current Ratio of 0.19. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.19, DOC is doing worse than 92.25% of the companies in the same industry.
A Quick Ratio of 0.19 indicates that DOC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.19, DOC is doing worse than 92.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 |
3. Growth
3.1 Past
DOC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.94%.
The Earnings Per Share has been decreasing by -2.64% on average over the past years.
Looking at the last year, DOC shows a quite strong growth in Revenue. The Revenue has grown by 15.91% in the last year.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.84% yearly.
EPS 1Y (TTM)-48.94%
EPS 3Y-2.7%
EPS 5Y-2.64%
EPS Q2Q%-76.19%
Revenue 1Y (TTM)15.91%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%-0.17%
3.2 Future
Based on estimates for the next years, DOC will show a decrease in Earnings Per Share. The EPS will decrease by -2.84% on average per year.
DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.98% yearly.
EPS Next Y-32.91%
EPS Next 2Y-9.91%
EPS Next 3Y-7.98%
EPS Next 5Y-2.84%
Revenue Next Year3.49%
Revenue Next 2Y3.41%
Revenue Next 3Y3.56%
Revenue Next 5Y3.98%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 80.71, which means the current valuation is very expensive for DOC.
Compared to the rest of the industry, the Price/Earnings ratio of DOC is on the same level as its industry peers.
When comparing the Price/Earnings ratio of DOC to the average of the S&P500 Index (27.86), we can say DOC is valued expensively.
Based on the Price/Forward Earnings ratio of 68.19, the valuation of DOC can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.71 | ||
| Fwd PE | 68.19 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as DOC.
Based on the Price/Free Cash Flow ratio, DOC is valued a bit cheaper than the industry average as 72.87% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.5 | ||
| EV/EBITDA | 14.13 |
4.3 Compensation for Growth
DOC's earnings are expected to decrease with -7.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.91%
EPS Next 3Y-7.98%
5. Dividend
5.1 Amount
DOC has a Yearly Dividend Yield of 6.36%, which is a nice return.
DOC's Dividend Yield is a higher than the industry average which is at 6.68.
Compared to an average S&P500 Dividend Yield of 2.44, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.36% |
5.2 History
The dividend of DOC decreases each year by -2.76%.
DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
515.26% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
The Dividend Rate of DOC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP515.26%
EPS Next 2Y-9.91%
EPS Next 3Y-7.98%
19.37
+0.19 (+0.99%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners96.35%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change7.19%
Market Cap13.46B
Analysts78.33
Price Target21.49 (10.94%)
Short Float %2.3%
Short Ratio2.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.36% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP515.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.51%
Min EPS beat(2)-19.41%
Max EPS beat(2)12.38%
EPS beat(4)2
Avg EPS beat(4)-2.54%
Min EPS beat(4)-79.16%
Max EPS beat(4)76.02%
EPS beat(8)5
Avg EPS beat(8)13.23%
EPS beat(12)7
Avg EPS beat(12)53.56%
EPS beat(16)10
Avg EPS beat(16)40.84%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)2.05%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.97%
Revenue beat(12)7
Avg Revenue beat(12)-4.86%
Revenue beat(16)11
Avg Revenue beat(16)-3.43%
PT rev (1m)-1.36%
PT rev (3m)-5.67%
EPS NQ rev (1m)-4.88%
EPS NQ rev (3m)-10.86%
EPS NY rev (1m)-6.53%
EPS NY rev (3m)-4.88%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.71 | ||
| Fwd PE | 68.19 | ||
| P/S | 4.81 | ||
| P/FCF | 26.5 | ||
| P/OCF | 10.81 | ||
| P/B | 1.7 | ||
| P/tB | 1.86 | ||
| EV/EBITDA | 14.13 |
EPS(TTM)0.24
EY1.24%
EPS(NY)0.28
Fwd EY1.47%
FCF(TTM)0.73
FCFY3.77%
OCF(TTM)1.79
OCFY9.25%
SpS4.02
BVpS11.41
TBVpS10.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 2.07% | ||
| ROCE | 2.62% | ||
| ROIC | 2.07% | ||
| ROICexc | 2.08% | ||
| ROICexgc | 2.27% | ||
| OM | 17.78% | ||
| PM (TTM) | 5.87% | ||
| GM | 60.51% | ||
| FCFM | 18.17% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexcg growth 3Y3.4%
ROICexcg growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 17.8 | ||
| Debt/EBITDA | 5.7 | ||
| Cap/Depr | 67.65% | ||
| Cap/Sales | 26.35% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.47% | ||
| Profit Quality | 309.77% | ||
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 | ||
| Altman-Z | 0.47 |
F-Score6
WACC6.48%
ROIC/WACC0.32
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.94%
EPS 3Y-2.7%
EPS 5Y-2.64%
EPS Q2Q%-76.19%
EPS Next Y-32.91%
EPS Next 2Y-9.91%
EPS Next 3Y-7.98%
EPS Next 5Y-2.84%
Revenue 1Y (TTM)15.91%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%-0.17%
Revenue Next Year3.49%
Revenue Next 2Y3.41%
Revenue Next 3Y3.56%
Revenue Next 5Y3.98%
EBIT growth 1Y-14.85%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year233.47%
EBIT Next 3Y53.55%
EBIT Next 5Y32.75%
FCF growth 1Y28322.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.95%
OCF growth 3Y10.42%
OCF growth 5Y4.82%